Medical devices, healthcare technology and the business of care
510(k) clearance · K260156

TruVision Single-Use 1.9mm Arthroscopy System

Nexus CMF, LLC · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK260156

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-09 for K260156, the TruVision Single-Use 1.9mm Arthroscopy System, submitted by Nexus CMF, LLC of Salt Lake City, Utah. The record lists the device classification as Arthroscope under regulation 888.1100, product code HRX, with an Orthopedic medical specialty and review panel. The application was received 01/20/2026 as a Traditional 510(k); the record states it was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan.

SESE in a 510(k) means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The public record does not identify the predicate device, summarize the comparative data, or describe indications, components or use instructions, so those details remain unknown from this source. The same decision appears in the FDA final-decisions listing dated 09 Oct 2026.

No clinical or legal conclusion about the device's performance or labeling is supported by the available fields.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260156
Regulatory pathway
510(k) premarket notification
Product code
HRX
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Arthroscope.

Product code
HRX
FDA device class
2

FDA decision timeline

  1. K260156 received

    Application receipt date recorded by FDA.

  2. K260156 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HRX

Product / regulatory recordCompanyPathwayDecision dateSource
SurGenTec, LLC510(k) clearanceOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Nexus CMF, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Salt Lake City, UT

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records